Matthew Zuga

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ABOS

Current role

CFO

1 call Latest call 2024-03-26

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Acumen Pharmaceuticals, Inc. (ABOS)	Chief Financial Officer and Chief Business Officer	$486,993	—	$123,580	$143,429	$172,980	$21,807	$948,789
2024	Acumen Pharmaceuticals, Inc. (ABOS)	Chief Financial Officer and Chief Business Officer	$468,263	—	$448,380	$537,977	$215,776	$19,118	$1,689,514
2023	Acumen Pharmaceuticals, Inc. (ABOS)	Chief Financial Officer and Chief Business Officer	$450,253	—	$204,685	$699,003	$234,131	$18,217	$1,606,289
2022	Acumen Pharmaceuticals, Inc. (ABOS)	Chief Financial Officer and Chief Business Officer	$429,836	—	—	$580,500	$163,148	$15,302	$1,188,786
2021	Acumen Pharmaceuticals, Inc. (ABOS)	Chief Financial Officer and Chief Business Officer	$315,430	$55,000	—	$257,280	$150,921	$200	$778,831

Earnings-call appearances and filed executive appointments or departures, newest first.